Clinical measurement of blood flow in tumours using positron emission tomography: a review

Nucl Med Commun. 2002 Feb;23(2):131-8. doi: 10.1097/00006231-200202000-00004.


In oncology drug development there is an increasing need for the in vivo physiological measurement of changes in tumour blood flow in response to therapy. Positron Emission Tomography (PET) is being increasingly used in oncology patients to measure blood flow. Here we review the clinical use of PET to measure vascular parameters in man.

Publication types

  • Review

MeSH terms

  • Breast Neoplasms / blood supply*
  • Breast Neoplasms / diagnostic imaging*
  • Cerebrovascular Circulation
  • Coronary Circulation / physiology
  • Gastrointestinal Neoplasms / blood supply*
  • Gastrointestinal Neoplasms / diagnostic imaging*
  • Humans
  • Models, Cardiovascular*
  • Radiopharmaceuticals
  • Regional Blood Flow
  • Tomography, Emission-Computed / methods*
  • Tomography, Emission-Computed / trends


  • Radiopharmaceuticals